# MongoDB, Inc.: Form 10-Q for the period ended Oct 31, 2022

- Company: [MongoDB, Inc.](/companies/mdb.md) (CIK 1441816)
- Form: 10-Q
- Filed: 2022-12-08
- Accepted by EDGAR: Dec 8, 2022, 17:11 ET
- Period: 2022-10-31
- Accession: 0001441816-22-000193
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1441816/000144181622000193/mdb-20221031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1441816/000144181622000193/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-10-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-08-01 to 2022-10-31 | $333.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2022-02-01 to 2022-10-31 | $922.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-08-01 to 2022-10-31 | $93.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2022-02-01 to 2022-10-31 | $260.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2022-08-01 to 2022-10-31 | $240.0m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2022-02-01 to 2022-10-31 | $662.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2022-08-01 to 2022-10-31 | $106.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2022-02-01 to 2022-10-31 | $310.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2022-08-01 to 2022-10-31 | −$82.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-02-01 to 2022-10-31 | −$273.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-08-01 to 2022-10-31 | $2.5m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2022-02-01 to 2022-10-31 | $7.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-08-01 to 2022-10-31 | $5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-02-01 to 2022-10-31 | $9.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-08-01 to 2022-10-31 | −$84.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-02-01 to 2022-10-31 | −$281.0m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2022-08-01 to 2022-10-31 | −$1.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-02-01 to 2022-10-31 | −$4.11 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2022-02-01 to 2022-10-31 | −$38.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-02-01 to 2022-10-31 | $6.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-10-31 | $999.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-10-31 | $2.12bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-10-31 | $2.47bn | us-gaap:Assets |
| Current liabilities | at 2022-10-31 | $517.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-10-31 | $1.78bn | us-gaap:Liabilities |
| Shareholders' equity | at 2022-10-31 | $684.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1441816/000144181622000193/mdb-20221031.htm

Filed Dec 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001441816-22-000193. Last ingested by Listed: Nov 4, 2026, 18:24 ET. No prices; not investment advice.
